Generate Biomedicines, Inc. shares its Q3 2026 financial results, showcasing progress in its pharmaceutical pipeline and collaborations.
| Name | Generate Biomedicines, Inc. |
|---|---|
| CIK | 0002100782 |
| Tickers | GENB |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | <br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 831630228 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 888-469-0055 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Generate Biomedicines, Inc. shares its Q3 2026 financial results, showcasing progress in its pharmaceutical pipeline and collaborations.
Generate Biomedicines, Inc. announces its financial results for the third quarter of 2026, showcasing growth in the pharmaceutical preparations sector.
Frances Arnold, Director of Generate Biomedicines, sells 11,409 shares in a recent SEC filing, impacting perceptions in the pharmaceutical industry.
58 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-456921 | 001-43165 | 261543158 | 34 | 563715 | 1 | 1 |
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-456890 | 001-43165 | 261543103 | 34 | 12300751 | 1 | 1 | |
| 2026-11-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002749 | 005-95695 | 261526163 | 34 | 11357 | |||
| 2026-11-04 | 4 | 4 | 0001193125-26-447199 | 6413 | ||||||
| 2026-10-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007553 | 001-43165 | 261501945 | 33 | 5539 | |||
| 2026-09-03 | 4 | 4 | 0001193125-26-381875 | 6411 | ||||||
| 2026-09-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006666 | 001-43165 | 261355093 | 33 | 4982 | |||
| 2026-09-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-006611 | 001-43165 | 261351207 | 33 | 4343 | |||
| 2026-08-26 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-365556 | 001-43165 | 261317238 | 34 | 1231195 | 1 | 1 |
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-336437 | 001-43165 | 261245649 | 34 | 11712040 | 1 | 1 | |
| 2026-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-336462 | 001-43165 | 261245646 | 34 | 544560 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-226574 | 005-95695 | 26986560 | 34 | 117377 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-225441 | 005-95695 | 26982600 | 34 | 6820 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-210059 | 001-43165 | 26950575 | 34 | 10648505 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-209899 | 001-43165 | 26950564 | 34 | 417836 | 1 | 1 |
| 2026-03-12 | 3 | 3 | 0000950130-26-000106 | 4785 | ||||||
| 2026-03-06 | 4 | 4 | 0001193125-26-096799 | 6324 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085952 | 5238 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085939 | 6822 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085928 | 5132 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085911 | 5299 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085910 | 5304 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085903 | 5182 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085898 | 12040 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085888 | 56978 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085886 | 7559 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085883 | 13345 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085881 | 10308 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085872 | 6579 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085871 | 5239 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085861 | 5130 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-085855 | 54950 | ||||||
| 2026-03-02 | 8-K | 8-K | 5.03,9.01 | 0001193125-26-085780 | 001-43165 | 26709491 | 34 | 479436 | 1 | 1 |
| 2026-02-27 | S-8 | S-8 | 0001193125-26-083253 | 333-293898 | 26702028 | 33 | 300682 | 1 | 1 | |
| 2026-02-27 | 424B4 | 424B4 | 0001193125-26-083190 | 333-293204 | 26701809 | 33 | 51511795 | |||
| 2026-02-26 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000677 | 333-293204 | 26692324 | 33 | 1735 | ||
| 2026-02-26 | 3 | 3 | 0001193125-26-078748 | 34358 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078738 | 32272 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078483 | 25782 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078427 | 21902 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078419 | 20327 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078415 | 17432 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078413 | 19320 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078412 | 21588 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078405 | 15995 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078404 | 23721 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078397 | 20452 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078395 | 24245 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078385 | 19380 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078381 | 15610 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078355 | 23770 | ||||||
| 2026-02-26 | 3 | 3 | 0001193125-26-078349 | 17709 | ||||||
| 2026-02-26 | CERT | GENB_8A_Cert_2100782.pdf | 0001354457-26-000222 | 001-43165 | 26686924 | 34 | 583503 | |||
| 2026-02-24 | 8-A12B | 8-A12B | 0001193125-26-067219 | 001-43165 | 26672219 | 34 | 40871 | |||
| 2026-02-23 | S-1/A | S-1/A | 0001193125-26-062362 | 333-293204 | 26662014 | 33 | 54289989 | 1 | 1 | |
| 2026-02-13 | S-1/A | S-1/A | 0001193125-26-051761 | 333-293204 | 26634546 | 33 | 2646277 | |||
| 2026-02-04 | S-1 | S-1 | 0001193125-26-037799 | 333-293204 | 26599235 | 33 | 61503015 | 1 | 1 | |
| 2025-12-23 | DRS | filename1.htm | 0001193125-25-330964 | 377-08875 | 251600805 | 33 | 54180508 |
One latest value per concept from companyfacts (124 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 129.10M | 2026-10-29 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 7.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 58.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -264,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.27B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 8.06M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 22.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 23.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | Assets | Assets | USD | 515.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 414.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | USD | 600,000 | 2023-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities | USD | 2.10M | 2023-06-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 720,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 140.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 404.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 144.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 18.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 30.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 129.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 129.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 129,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -216.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | USD | -268,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -217.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 69.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 266,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions | Holding | 61 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 7.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 10.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | DepreciationNonproduction | Depreciation, Nonproduction | USD | 10.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 11.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 363,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 12.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 5.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 3.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -62,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 40.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | HeldToMaturitySecuritiesFairValue | Debt Securities, Held-to-maturity, Fair Value | USD | 183.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -216.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 130,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 4.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 2.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -17.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -6.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -116,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 2.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -2.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 529,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 11.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 987,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | Liabilities | Liabilities | USD | 134.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 515.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 82.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 263.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 381.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -170.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -193.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -216.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | -268,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -224.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 10.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 244.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -227.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 10.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 46.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 53.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 9.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -370,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 3.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 469.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 6.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | PreferredStockConvertibleSharesIssuable | PreferredStockConvertibleSharesIssuable | shares | 69.33M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-03-02 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-03-02 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 10.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 369.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ProceedsFromMinorityShareholders | Proceeds from Noncontrolling Interests | USD | 7.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 305.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 8.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -216.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 97.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 38.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross | Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross | USD | 73.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 204.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 4.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -892.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 17.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 14.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 425,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 22.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.823 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 381.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.658 | 2026-02-01 | 2026-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 811.83M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 369.29M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 46,000 | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 4.85M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | TemporaryEquityDividendsAdjustment | Temporary Equity, Dividends, Adjustment | USD | 7.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 960.45M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 113.96M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 107.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 107.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456890 |